225 related articles for article (PubMed ID: 29878115)
1. AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.
Hughes MP; Smith DA; Morris L; Fletcher C; Colaco A; Huebecker M; Tordo J; Palomar N; Massaro G; Henckaerts E; Waddington SN; Platt FM; Rahim AA
Hum Mol Genet; 2018 Sep; 27(17):3079-3098. PubMed ID: 29878115
[TBL] [Abstract][Full Text] [Related]
2. A Novel Small
Hughes MP; Nelvagal HR; Coombe-Tennant O; Smith D; Smith C; Massaro G; Poupon-Bejuit L; Platt FM; Rahim AA
Cells; 2023 Jun; 12(12):. PubMed ID: 37371089
[TBL] [Abstract][Full Text] [Related]
3. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
Xie C; Gong XM; Luo J; Li BL; Song BL
J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
[TBL] [Abstract][Full Text] [Related]
4. Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.
Chandler RJ; Williams IM; Gibson AL; Davidson CD; Incao AA; Hubbard BT; Porter FD; Pavan WJ; Venditti CP
Hum Mol Genet; 2017 Jan; 26(1):52-64. PubMed ID: 27798114
[TBL] [Abstract][Full Text] [Related]
5. Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
Hung YH; Walterfang M; Churilov L; Bray L; Jacobson LH; Barnham KJ; Jones NC; O'Brien TJ; Velakoulis D; Bush AI
Neurotherapeutics; 2016 Jul; 13(3):614-22. PubMed ID: 26942423
[TBL] [Abstract][Full Text] [Related]
6. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.
Rodriguez-Gil JL; Watkins-Chow DE; Baxter LL; Elliot G; Harper UL; Wincovitch SM; Wedel JC; Incao AA; Huebecker M; Boehm FJ; Garver WS; Porter FD; Broman KW; Platt FM; Pavan WJ
Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996359
[TBL] [Abstract][Full Text] [Related]
7. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
[TBL] [Abstract][Full Text] [Related]
8. Altered transition metal homeostasis in Niemann-Pick disease, type C1.
Hung YH; Faux NG; Killilea DW; Yanjanin N; Firnkes S; Volitakis I; Ganio G; Walterfang M; Hastings C; Porter FD; Ory DS; Bush AI
Metallomics; 2014 Mar; 6(3):542-53. PubMed ID: 24343124
[TBL] [Abstract][Full Text] [Related]
9. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization.
Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM
Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112
[TBL] [Abstract][Full Text] [Related]
10. Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder.
Lopez ME; Klein AD; Dimbil UJ; Scott MP
J Neurosci; 2011 Mar; 31(12):4367-78. PubMed ID: 21430138
[TBL] [Abstract][Full Text] [Related]
11. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
Williams IM; Wallom KL; Smith DA; Al Eisa N; Smith C; Platt FM
Neurobiol Dis; 2014 Jul; 67():9-17. PubMed ID: 24631719
[TBL] [Abstract][Full Text] [Related]
12. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
[TBL] [Abstract][Full Text] [Related]
14. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.
Lloyd-Evans E; Morgan AJ; He X; Smith DA; Elliot-Smith E; Sillence DJ; Churchill GC; Schuchman EH; Galione A; Platt FM
Nat Med; 2008 Nov; 14(11):1247-55. PubMed ID: 18953351
[TBL] [Abstract][Full Text] [Related]
16. Normalization of Hepatic Homeostasis in the
Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
[TBL] [Abstract][Full Text] [Related]
17. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
18. Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.
Brogden G; Shammas H; Walters F; Maalouf K; Das AM; Naim HY; Rizk S
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204338
[TBL] [Abstract][Full Text] [Related]
19. Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.
Meyer A; Wree A; Günther R; Holzmann C; Schmitt O; Rolfs A; Witt M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383485
[TBL] [Abstract][Full Text] [Related]
20. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]